Cargando…
Polymorphism of ORM1 Is Associated with the Pharmacokinetics of Telmisartan
BACKGROUND: The pharmacokinetics (PKs) and pharmacodynamics (PDs) of telmisartan varies among the individuals, and the main causes remain unknown. The aim of this study was to evaluate the impact of ORM1, as well as ABCC2, ABCB1, ABCG2 and SLCO1B3 polymorphisms, on the disposition of the drug and BP...
Autores principales: | Chen, Wang-Qing, Shu, Yan, Li, Qing, Xu, Lin-Yong, Roederer, Mary W., Fan, Lan, Wu, Lan-Xiang, He, Fa-Zhong, Luo, Jian-Quan, Tan, Zhi-Rong, He, Yi-Jing, Zhou, Hong-Hao, Chen, Xiang, Zhang, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3734062/ https://www.ncbi.nlm.nih.gov/pubmed/23940561 http://dx.doi.org/10.1371/journal.pone.0070341 |
Ejemplares similares
-
Persistence in PHP with the doctrine ORM
por: Dunglas, Kévin
Publicado: (2013) -
Sulle orme di Carnot
por: Carrà, Sergio
Publicado: (2011) -
ORM 1 as a biomarker of increased vascular invasion and decreased sorafenib sensitivity in hepatocellular carcinoma
por: Gu, Jiangning, et al.
Publicado: (2022) -
Orm family proteins mediate sphingolipid homeostasis
por: Breslow, David K., et al.
Publicado: (2010) -
Reply to Dr. Orme’s “Anti-Vaccination Nuts”
por: Clarke, W. B.
Publicado: (1898)